MBL2 and systemic lupus erythematosus: Further study showed that IL-17+CD4+ and IFN-γ+CD4+ T cells in lupus mice injected with ALD-DNA/MBL–treated macrophages were decreased significantly as compared with those in lupus mice injected with ALD-DNA–treated macrophages (Figure S4A and S4B).